1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Peripheral circulatory conditions

Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease

Technology appraisal guidance [TA223] Published: 25 May 2011

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Overview
  • 1 Guidance
  • 2 Clinical need and practice
  • 3 The technologies
  • 4 Evidence and interpretation
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Related NICE guidance
  • 8 Review of guidance
  • Appendix A: Appraisal Committee members, guideline representative and NICE project team
  • Appendix B: Sources of evidence considered by the Committee
  • Changes after publication
  • About this guidance
Download guidance (PDF)

Guidance

  • Next

7 Related NICE guidance

  • Published
  • Under development

7 Related NICE guidance

Published

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of NICE technology appraisal guidance 90). NICE technology appraisal guidance 210 (2010).

Under development

NICE is developing the following guidance (details available from the NICE website):

  • Lower limb peripheral arterial disease. NICE clinical guideline. Publication expected October 2012.

  • National Institute for Health and Care Excellence (NICE)

  • Next